Grace Therapeutics
GRCE
#10502
Rank
$34.66 M
Marketcap
$2.13
Share price
0.47%
Change (1 day)
-31.29%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2026 (TTM): -$9.5 Million USD

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$7 Million USD, an increase over its 2024 earnings that were of -$16.44 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$9.5 Million35.67%
2025 -$7 Million-57.44%
2024 -$16.44 Million-66.16%
2023 -$48.59 Million161.72%
2022 -$18.57 Million60.58%
2021 -$11.57 Million-462.11%
2020 $3.19 M
2018 -$25.15 Million
2015 -$4.08 Million
2013 -$9.92 Million49.55%
2012 -$6.64 Million